The relationship between pharma and the NHS is challenging, not cosy

A spoon with tablets on it

The three-cornered partnership between the NHS, pharma and academic medicine can only benefit from a more open culture, says Timothy Evans.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here